Showing 19,121 - 19,140 results of 25,426 for search '(( significant ((clinical decrease) OR (clinical case)) ) OR ( significant decrease decrease ))', query time: 0.56s Refine Results
  1. 19121

    Pan-cancer analysis reveals PRRT4 is a potential prognostic factor of AML by Wenqiong Xiang (17738962)

    Published 2025
    “…After PRRT4 knockdown, the proliferation ability of THP1 cells was significantly enhanced, and the apoptosis ratio was significantly decreased.…”
  2. 19122

    Data Sheet 1_The burden of rare cancers among adults in the Canton of Geneva, Switzerland, from 2011 to 2020.xlsx by Nathalie Bot (21006311)

    Published 2025
    “…Introduction<p>Globally, cancer cases are expected to significantly increase due to population growth and aging, reaching 29.9 million by 2040 (+49.5% since 2022) and 32.6 million by 2045 (+63%), with countries like Switzerland forecasting a 36.5% increase. …”
  3. 19123

    Table 1_The burden of rare cancers among adults in the Canton of Geneva, Switzerland, from 2011 to 2020.docx by Nathalie Bot (21006311)

    Published 2025
    “…Introduction<p>Globally, cancer cases are expected to significantly increase due to population growth and aging, reaching 29.9 million by 2040 (+49.5% since 2022) and 32.6 million by 2045 (+63%), with countries like Switzerland forecasting a 36.5% increase. …”
  4. 19124

    Data Sheet 1_Efficacy and safety of Tongxinluo capsules combined with conventional therapy for acute myocardial infarction: a systematic review and meta-analysis.zip by Dan Ouyang (554436)

    Published 2025
    “…The meta-analysis revealed that Tongxinluo capsule combined with conventional treatment significantly decreased the 1-month MACCE rate (RR = 0.62, 95% CI 0.47 to 0.81; p = 0.0007), along with the individual risks of 1-month MACCE, including cardiac death (RR = 0.68, 95% CI 0.50 to 0.93; p = 0.02) and myocardial reinfarction (RR = 0.11, 95% CI 0.01 to 0.94; p = 0.04). …”
  5. 19125

    Data Sheet 2_Efficacy and safety of Tongxinluo capsules combined with conventional therapy for acute myocardial infarction: a systematic review and meta-analysis.zip by Dan Ouyang (554436)

    Published 2025
    “…The meta-analysis revealed that Tongxinluo capsule combined with conventional treatment significantly decreased the 1-month MACCE rate (RR = 0.62, 95% CI 0.47 to 0.81; p = 0.0007), along with the individual risks of 1-month MACCE, including cardiac death (RR = 0.68, 95% CI 0.50 to 0.93; p = 0.02) and myocardial reinfarction (RR = 0.11, 95% CI 0.01 to 0.94; p = 0.04). …”
  6. 19126

    Global prevalence of autoimmune diseases in turner syndrome: a systematic review and meta-analysis by Seongbeen Hwang (22629057)

    Published 2025
    “…Conversely, the prevalence of psoriasis (1.14%) did not differ significantly, whereas the prevalence of vitiligo (0.84%) was significantly lower.…”
  7. 19127

    Table 1_Effectiveness of Five-Element Regulatory Therapy for post-COVID syndrome: a retrospective cohort study.docx by Ning Ding (456674)

    Published 2025
    “…</p>Results<p>The FERT group demonstrated superior clinical outcomes, achieving a 61.7% cure rate and 88.9% response rate, significantly higher than the control group’s 21.7% (p < 0.001) and 67.4% (p < 0.01), respectively.…”
  8. 19128

    Table 1_Nationwide trends in steroid therapy for vestibular neuritis: insights from South Korea’s health insurance review and assessment data.docx by Chul Young Yoon (16970190)

    Published 2025
    “…Prescription rates declined significantly in patients aged 55 years and older. Outpatients (87.2%) and those treated in clinics (65.1% for males, 75.3% for females) were more likely to receive steroids. …”
  9. 19129

    Table 1_Weizmannia coagulans BC99 regulates oxidative stress and serum metabolic pathways to improve allergic rhinitis: a randomized, double-blind, placebo-controlled trial.docx by Xuan Li (137217)

    Published 2025
    “…Furthermore, BC99 supplementation significantly decreased serum IgA, complement C3, EOS, and MDA levels (p < 0.05) while enhancing antioxidant capacity (increased GSH, stabilized SOD). …”
  10. 19130

    Table 2_Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.xlsx by Pan Ding (2485819)

    Published 2025
    “…The top 5 drugs most frequently linked to kidney stone cases were adalimumab (2,636 cases), infliximab (1,266 cases), interferon beta-1a (920 cases), sodium oxybate (877 cases), and teriparatide (836 cases). …”
  11. 19131

    Table 1_Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.docx by Pan Ding (2485819)

    Published 2025
    “…The top 5 drugs most frequently linked to kidney stone cases were adalimumab (2,636 cases), infliximab (1,266 cases), interferon beta-1a (920 cases), sodium oxybate (877 cases), and teriparatide (836 cases). …”
  12. 19132

    Table 3_Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.xlsx by Pan Ding (2485819)

    Published 2025
    “…The top 5 drugs most frequently linked to kidney stone cases were adalimumab (2,636 cases), infliximab (1,266 cases), interferon beta-1a (920 cases), sodium oxybate (877 cases), and teriparatide (836 cases). …”
  13. 19133

    Figure 4 from Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate Micronuclei by Fabian R. Villagomez (18098633)

    Published 2025
    “…<p>Correlation of amino acids transport with the clinical significance of claudin-4 in ovarian cancer. …”
  14. 19134

    Table 1_Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study.xlsx by Miklós Darida (18718078)

    Published 2025
    “…Background<p>Despite well-documented clinical differences across breast-cancer (BC) molecular subtypes and relevant changes in therapeutic interventions over the past decades, there remains a significant lack of up-to-date epidemiologic data and real-world outcomes, particularly in Central and Eastern Europe.…”
  15. 19135

    Table 2_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.xlsx by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  16. 19136

    Image 1_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.tif by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  17. 19137

    Image 2_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.tif by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  18. 19138

    Table 1_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.docx by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  19. 19139

    Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival by Fangqing Wang (11838502)

    Published 2024
    “…More complex autoantibody profiles may be observed in SSc overlap syndrome (SSc OS). To determine the clinical significance of autoantibodies in SSc OS and classify the patients more accurately for better disease assessments, we analysed the correlation between serological profiles, organ involvements and outcomes.…”
  20. 19140

    Data Sheet 1_Exploring the therapeutic potential of “Zhi-Zhen” formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatic... by Yongjing Li (3821944)

    Published 2025
    “…Among these targets, the differential expression of CASP7 significantly affected the progression-free survival of patients with CRC. …”